Loratadine

Verify with FDA CVM →

95 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
95
Total Reports
12
Deaths Reported
1260.0%
Death Rate

Active Ingredients

Loratadine

Administration Routes

OralUnknown

Species Affected

Dog 82
Cat 7
Human 6

Most Affected Breeds

Retriever - Labrador 10
Retriever - Golden 6
Unknown 6
Shih Tzu 5
Shepherd Dog - German 4
Beagle 4
Sheepdog - Shetland 4
Spaniel - Springer English 3
Spaniel - Cocker American 3
Terrier - Yorkshire 3

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 15
Diarrhoea 15
Vomiting 14
Panting 9
Lack of efficacy - NOS 8
Emesis 7
Death by euthanasia 7
Other abnormal test result NOS 7
Polydipsia 6
Behavioural disorder NOS 5
Elevated blood urea nitrogen (BUN) 5
Elevated creatinine 5

Outcome Breakdown

Recovered/Normal
39 (41.1%)
Outcome Unknown
31 (32.6%)
Ongoing
13 (13.7%)
Euthanized
8 (8.4%)
Died
4 (4.2%)

Data Summary

Metric Value
Total adverse event reports 95
Reports involving death 12
Case-fatality rate (reported events) 1260.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Loratadine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 95 adverse event reports referencing Loratadine, including 12 reports in which the animal died — a 1260.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Loratadine. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Loratadine reports are Dog (82 reports), Cat (7 reports), Human (6 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (10), Retriever - Golden (6), Unknown (6) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Loratadine are Lethargy (see also Central nervous system depression in 'Neurological') (15), Diarrhoea (15), Vomiting (14), Panting (9). Of the 95 reports with a coded outcome, Recovered/Normal is the leading category at 41.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Loratadine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial